A severe bleeding disorder in Simmental cattle has been described in widespread locations in the USA and Canada. The clinical findings are consistent with a hemophilia-like disease or, more precisely, a hereditary hemorrhagic diathesis and include spontaneous epistaxis, hematuria, and excessive bleeding associated with trauma or standard management procedures such as tattooing, ear tagging, and castration. A preliminary investigation of this defect showed that blood-platelet numbers and coagulation profiles of affected cattle were normal. Affected animals have a marked dysfunction of platelets (thrombopathy), termed Simmental hereditary thrombopathy. The defect is very similar or identical to that described in the same breed by 2 other laboratories.
A bleeding disorder of Simmental cattle was first described in 1977 and 1980. 7, 9 This apparently autosomal recessive defect was associated with a mild to severe bleeding tendency that was exacerbated by trauma. Clinical findings included spontaneous epistaxis, hematuria, and excessive blood loss associated with injury, all of which are consistent with defective platelet function. Platelets from affected animals exhibited impaired aggregation when stimulated with adenosine diphosphate (ADP) or collagen. Platelet dense body granule serotonin and nucleotide concentrations were normal.
A 1990 report 12 from Canada described a similar, A purebred Simmental cow was presented to the potentially fatal bleeding disorder in 8 Simmental cattle. Platelet numbers and ultrastructu ral morphology and coagulation screening tests were normal in these animals. In whole blood aggregation studies, platelets from affected animals did not aggregate following stimulation with ADP.
thromboplastin time, fibrin degradation products, and fibrinogen, was also within normal limits. Because of the severity of the clinical disease, the owner elected to donate the dam to Michigan State University. A second similarly affected purebred Simmental heifer and a male Simmental calf were identified in 1990 and 1992, respectively, and were purchased by the university to enhance the studies of platelet function in this defect.
To further characterize the defect present in Simmental hereditary thrombopathy, in vitro aggregation of affected platelets was measured in response to a variety of agonists that activate platelets by different mechanisms. Samples of resting and poststimulation platelets were collected for transmission electron microscopy studies to evaluate platelet morphology and to confirm the results of the aggregation studies. Gelfiltered platelets were maintained in a range of concentrations of external calcium and were stimulated Veterinary Teaching Hospital, Michigan State Uni-by thrombin to evaluate the effect of external calcium on the aggregation response. This paper reports specific versity, in November 1989 with a history of recurrent clinical diagnostic characteristics of the platelet funcepistaxis and hematoma formation associated with mi-tion defect in purebred Simmental cattle. nor trauma. Following a difficult but successful calving, severe anemia, massive internal hematoma formation, edly elevated pulse and respiratory rates, and exhibited ep-Received for publication July 13, 1992. istaxis. There were multiple large swellings over the posterior hip and thigh region, principally involving the right semitendinosus area and the vulva. In addition, multiple prominent masses were palpated within the soft tissue structures of the pelvic canal. Cytologic examination results of needle aspirates from the external masses were consistent with hematomas. Attempts to parenterally treat the heifer or to obtain blood samples resulted in localized hematoma formation and/or prolonged bleeding from injection sites. Initial clinical pathologic data revealed the animal to be anemic (PCV = 14%) with leukocytosis (white blood cell [WBC] count = 14,500/µ1). The WBC differential breakdown was consistent with physiologic leukocytosis, a response commonly seen in cattle during parturition. The platelet count was normal (360,000/µ1). Results of a coagulation profile, including prothrombin time, activated partial thromboplastin time, fibrinogen (quantitative), and fibrin degradation products, were normal.
Animal no. 2. In June 1990, a yearling purebred Simmental heifer was presented to the Michigan State University Large Animal Teaching Hospital with a history of sudden formation of a mass over the right dorsolateral pelvic area. The heifer's previous health records indicated a tendency toward prolonged bleeding following minor cuts or abrasions and recurrent epistaxis. On physical examination, a mass approximately 10 x 15 cm was noted over the right hip area. The skin surface overlying the mass appeared normal; however, the animal exhibited a mild pain response when the area was palpated. The heifer was otherwise in good condition. A complete blood count was normal. The platelet count and coagulation profile results were also within normal ranges.
Animal no. 3. The owner of a 2-wk-old male Simmental calf reported that it appeared to bleed excessively following a routine ear tagging procedure. The hemorrhage decreased slightly when the animal was confined; however, it became noticeable again when the calf was allowed greater freedom of movement. Additional history included a tendency for the calf to experience prolonged bleeding from small lacerations over the head and back and the appearance of scleral bruising. The calf was moderately anemic (PCV = 17%); platelet count and coagulation profile results were within normal ranges. Evaluation of a platelet-rich plasma sample from the dam revealed normal aggregation studies.
Experimental subjects
The experimental group consisted of 2 affected Simmental cows, 1 affected male Simmental calf, and 3 control animals, 2 of which were Holstein cows and 1 was a Simmental steer. All animals were housed at Michigan State University and were free from clinical signs of disease other than those related to the thrombopathy.
Collection of platelets
Blood was collected by jugular venipuncture via an 18gauge needle into a plastic syringe containing trisodium citrate at a final concentration of 0.32%. Platelet-rich plasma (PRP) was obtained by multiple centrifugation of the blood at 1,324 x g for 60 sec and removal of a small quantity of PRP between each spin. Platelet-poor plasma (PPP) was obtained by centrifugation of the remaining blood at 1,324 x g for 13 min. Platelets were also gel filtered to remove plasma constituents for measurement of the aggregation response to thrombin. Gel-filtered platelets (GFP) were obtained by adding 1 µM prostaglandin E 1 to the PRP prior to centrifugation at 800 x g for 15 min. The platelet pellet was resuspended in 1 ml HEPES-Tyrode-albumin (HTA) buffer (130 mM NaCl, 2.6 mM KCl, 0.42 mM NaH 2 PO 4 , 5.5 mM dextrose, 0.01 mM HEPES, and 3.0 mg/ml bovine serum albumin, pH 7.2) and passed over a IO-ml Sepharose 4B a column, and the eluate was collected.
Aggregation studies
Aggregation studies were run in triplicate on each animal tested. The aggregation response to ADP, a platelet activating factor (PAF), a,b or calcium ionophore A23187 a,b was measured using PRP adjusted to a final concentration of 300,000 platelets/µ1 with autologous PPP. The platelets were manually counted using the Unopette system and a hemocytometer. The aggregation response to thrombin a was measured using GFP adjusted to a final concentration of 300,000 platelets/µ1 with HTA buffer to which MgCL 2 (1 mM) and CaCl 2 (1.5, 1.0., 0.5, or 0 mM) were added. The PRP/GFP suspensions were divided into 0.5-ml aliquots and rested at room temperature for 30 min.
The PRP/GFP was warmed to 37 C and stirred at 900 rpm. In an aggregometer, c agonist (20 µ1) was added, and aggregation profiles were evaluated by measuring the change in optical light transmission through the sample when compared with a standard (PPP for PRP samples and buffer for GFP samples). Light transmittance through the standard was considered to be 100%, and light transmittance through the resting platelet sample was considered to be 0%. Both maximum percent aggregation (indicative of the extent of aggregation) and maximum slope of the aggregation curve (indicative of the rate of aggregation) were measured. If the sample did not begin to aggregate within 5 min of agonist addition, the percent aggregation and slope were recorded as 0%.
Preparation of platelets for transmission electron microscopy (TEM)
The platelets were prepared as described previously. 10 The PRP/GFP was prepared as for the aggregation studies. Following agonist addition, the response was stopped at 1 or 5 min by the addition of 0.5 ml 0.1% glutaraldehyde in 0.1 M sodium cacodylate buffer, pH 7.4. The sample was stirred for 1 min prior to transfer into an Eppendorf d microcentrifuge tube for centrifugation for 20 set at 12,800 x g. The supernatant was discarded, and 1 ml of 3% glutaraldehyde in 0.1 M cacodylate buffer was added. The sample was allowed to fix for 3-6 hr, at which time the supernatant was discarded and 1 ml 0.1 M cacodylate buffer was added to the sample. Samples were then processed for TEM.
Results
Affected platelets had no aggregation response to ADP and calcium ionophore A23187; in the case of PAF and thrombin, the aggregation response was decreased or took longer to complete when compared with control bovine platelets under the same condi- tions (Fig. 1) . Platelets from the affected animals changed shape but did not aggregate in response to any concentration of ADP (1-100 µM) or calcium ionophore A23187 (10-40 µM) tested. In contrast, the control animal platelets changed shape and aggregated in response to ADP (3.5-10 µM) and calcium ionophore A23187 (20-40 µM) (Fig. 2) . Transmission electron microscopy confirmed the aggregation study results. On TEM, there were no differences in morphology of resting (nonstimulated) platelets between affected and control cattle (Fig. 3) .
In response to PAF. affected platelets changed shape and aggregated, though the extent of aggregation (maximum percent aggregation) was decreased relative to that of control platelets. Affected platelets also appeared to be less sensitive to PAF because control platelets aggregated at concentrations of 0.1 µM or less whereas affected platelets did not aggregate in response to 0.1 µM PAF or had a weak primary aggregation only.
Affected and control platelets responded similarly to higher concentrations of thrombin (1 or 0.6 U/ml). In response to 0.1 U/ml thrombin, the affected platelets had a decreased slope of the aggregation curve (data not shown), although the maximum percent aggregation was similar to that of the controls. At a concentration of 0.05 U/ml thrombin, control platelets exhibited irreversible aggregation, whereas affected platelets failed to aggregate (Fig. 1) .
Platelet-rich plasma samples from obligate carriers of this hereditary thrombopathy (the calf of animal no. 1 and the dam of animal no. 3) were evaluated for response to various agonists. Results were indistinguishable from the control data in this study.
Discussion
Simmental hereditary thrombopathy (SHT) is a functional primary platelet disorder in purebred Simmental cattle characterized by epistaxis, hematuria, and excessive hemorrhage following trauma or surgery. In vitro, platelet function is most commonly assessed by measuring the platelet responses of shape change, aggregation, and the release reaction. Shape change, which is the transformation of platelets from a smooth disc to a sphere with numerous pseudopodal projections, acterized by measuring platelet shape change and agcorrelates with the Ca ++ -dependent phosphorylation gregation responses to a variety of agonists. of myosin light-chain kinase. 13 Aggregation occurs fol-Isolated platelets do not respond to ADP or calcium lowing exposure of the platelet fibrinogen binding site ionophore A23187; similar findings in whole blood on membrane glycoprotein IIb-IIIa, allowing fibrinofrom affected animals have previously been described gen to form a bridge between adjacent platelets. 3, 13 In in response to ADP. 12 The SHT platelets changed shape the present study, the platelet defect in SHT was charbut did not aggregate, whereas control bovine platelets irreversibly aggregated. The occurrence of shape change indicates that SHT platelets have a functional receptor for the agonist being tested irrespective of their ability to aggregate. Because ADP and A23187 cause platelet aggregation by different mechanisms, the defect in SHT must be located in an activation pathway shared by both agonists. ADP binds to a specific membrane receptor(s), which transmits the stimulatory signal into the cell. 13 ADP activation of human platelets is associated with exposure of the fibrinogen binding site on the membrane glycoprotein IIb-IIIa complex, 3 increased cytosolic free ionized calcium concentrations, 11 and activation of phospholipase A, (PLA,). PLA, initiates the release of arachidonic acid metabolites (e.g., thromboxane A,), which subsequently activate phospholipase C (PLC). 15 PLC plays a central role in platelet activation by producing a variety of intracellular messengers that help regulate the platelet response. 15 Although bovine platelets produce thromboxane A, following ADP stimulation, the use of cyclooxygenase inhibitors does not interfere with normal bovine platelet aggregation, which suggests that the ADP-induced aggregation of bovine platelets, unlike that of human platelets, is independent of arachidonic acid metabolism. 2, 5 Calcium ionophore A23187 is a nonphysiologic agonist that does not bind to a specific receptor; instead, A23187 increases membrane permeability to calcium. 16 The subsequently increased concentration of cytosolic free ionized calcium then activates a number of Ca ++ -dependent intracellular enzymes, including myosin light-chain kinase, which phosphorylates myosin light chain and is associated with shape change, and PLA 2 , which releases arachidonic acid from membrane phospholipids. 13 Affected SHT platelets changed shape and aggregated in response to PAF or thrombin, although the response was decreased relative to that of the control bovine platelets. Both PAF and thrombin bind to specific surface receptors 13 that then activate PLC. 4, 8 Studies on normal bovine platelets have indicated that PLC plays an important role in mediating aggregation. 2 The present findings show that SHT platelets are able to aggregate when PLC is stimulated directly, although the decreased responsiveness to PAF indicates that there may be an additional pathway(s) that acts synergistically to amplify the platelet response and is absent or defective in affected platelets.
Transmission electron micrographs showed no ultrastructural differences between control bovine and than confirming the presence or absence of aggregation, the transmission electron micrographs did not reveal References any differences in poststimulation platelet morphology 1. Bell TG, Meyers KM, Prieur DJ, Fauci AS, Wolfe SM, Padgett between the two groups. GA: 1976 , Decreased nucleotide and serotonin storage asso-Preliminary data implicate a defect in calcium mobilization in affected platelets, possibly secondary to altered calcium transport across the plasma membrane. 14 Cytosolic free ionized calcium plays a pivotal role in platelet activation by regulating the activity of a number of Ca ++ -dependent enzymes and the organization of the cytoskeleton. 13 Normal bovine platelets mobilize calcium following stimulation? Affected SHT platelets appear to mobilize calcium, as indicated by the occurrence of shape change in response to all agonists tested. Shape change correlates with the release of internal stores of calcium but not with the external calcium concentration. 13 The thrombin-stimulated aggregation in control platelets was enhanced by increasing the concentration of external calcium, whereas the aggregation potential of affected platelets was relatively unresponsive to alterations in the external calcium. 14 This lack of response suggests that there may be a defect in the mechanism controlling the influx of external calcium in affected Simmental cattle and indicates that closer examination of the process of calcium mobilization is warranted.
The SHT platelets exhibit a unique pattern of dysfunction. This study revealed the differences between the SHT platelet defect and the other primary platelet disorders. The Chediak-Higashi Syndrome (CHS) of Hereford cattle has been extensively investigated. 1 This autosomal recessive disease is characterized by a primary thrombopathy, hypopigmentation, neutrophil defects, and altered immune functions. In SHT, the platelet response to 5 µM ADP is absent, whereas in CHS it is normal. The CHS platelet has a markedly decreased response to agents that require release of dense body granules, such as collagen.
Diagnostically, SHT platelets present a unique pattern of dysfunction. Further investigation of the biochemical pathways and modes of activation of normal and affected bovine platelets will aid in discovery of the basis of this defect.
